261 related articles for article (PubMed ID: 31615295)
1. Impact of Toll-like Receptors 2(TLR2) and TLR 4 Gene Variations on HCV Susceptibility, Response to Treatment and Development of Hepatocellular Carcinoma in Cirrhotic HCV Patients.
Neamatallah M; El-Bendary M; Elalfy H; Besheer T; El-Maksoud MA; Elhammady D; Abed S; Elegezy M; Kandeel L; Eldeib D; Mousa N; Abd El-Hafeez M; El-Gilany AH; Esmat G
Immunol Invest; 2020 May; 49(4):462-476. PubMed ID: 31615295
[No Abstract] [Full Text] [Related]
2. TLR3 and TLR4 SNP variants in the liver disease resulting from hepatitis B virus and hepatitis C virus infection.
Sghaier I; Zidi S; Mouelhi L; Ghazoueni E; Brochot E; Almawi WY; Loueslati BY
Br J Biomed Sci; 2019 Jan; 76(1):35-41. PubMed ID: 30421643
[TBL] [Abstract][Full Text] [Related]
3. The toll-like receptor 2 (TLR2) -196 to -174 del/ins polymorphism affects viral loads and susceptibility to hepatocellular carcinoma in chronic hepatitis C.
Nischalke HD; Coenen M; Berger C; Aldenhoff K; Müller T; Berg T; Krämer B; Körner C; Odenthal M; Schulze F; Grünhage F; Nattermann J; Sauerbruch T; Spengler U
Int J Cancer; 2012 Mar; 130(6):1470-5. PubMed ID: 21500195
[TBL] [Abstract][Full Text] [Related]
4. Association of MicroRNA 196a and 499 Polymorphisms with Development of Cirrhosis and Hepatocellular Carcinoma Post-HCV Infection in Egyptian Patients.
Fteah AM; Ahmed AI; Mosaad NA; Hassan MM; Mahmoud SH
Asian Pac J Cancer Prev; 2019 Nov; 20(11):3479-3485. PubMed ID: 31759375
[TBL] [Abstract][Full Text] [Related]
5. Association between Toll-Like Receptor 3 (TLR3) rs3775290, TLR7 rs179008, TLR9 rs352140 and Chronic HCV.
Mosaad YM; Metwally SS; Farag RE; Lotfy ZF; AbdelTwab HE
Immunol Invest; 2019 Apr; 48(3):321-332. PubMed ID: 30321082
[TBL] [Abstract][Full Text] [Related]
6. Polymorphism of the TLR4 gene reduces the risk of hepatitis C virus-induced hepatocellular carcinoma.
Agúndez JA; García-Martín E; Devesa MJ; Carballo M; Martínez C; Lee-Brunner A; Fernández C; Díaz-Rubio M; Ladero JM
Oncology; 2012; 82(1):35-40. PubMed ID: 22286521
[TBL] [Abstract][Full Text] [Related]
7. Vitamin D receptor rs3782905 and vitamin D binding protein rs7041 polymorphisms are associated with hepatocellular carcinoma susceptibility in cirrhotic HCV patients.
El-Masry AS; Medhat AM; El-Bendary M; Mohamed RH
BMC Med Genomics; 2023 Dec; 16(1):319. PubMed ID: 38066559
[TBL] [Abstract][Full Text] [Related]
8. The association between Toll-like receptor 2 single-nucleotide polymorphisms and hepatocellular carcinoma susceptibility.
Junjie X; Songyao J; Minmin S; Yanyan S; Baiyong S; Xiaxing D; Jiabin J; Xi Z; Hao C
BMC Cancer; 2012 Feb; 12():57. PubMed ID: 22309608
[TBL] [Abstract][Full Text] [Related]
9. HCV-related liver and lymphoproliferative diseases: association with polymorphisms of IL28B and TLR2.
De Re V; De Zorzi M; Caggiari L; Lauletta G; Tornesello ML; Fognani E; Miorin M; Racanelli V; Quartuccio L; Gragnani L; Russi S; Pavone F; Ghersetti M; Costa EG; Casarin P; Bomben R; Mazzaro C; Basaglia G; Berretta M; Vaccher E; Izzo F; Buonaguro FM; De Vita S; Zignego AL; De Paoli P; Dolcetti R
Oncotarget; 2016 Jun; 7(25):37487-37497. PubMed ID: 27183918
[TBL] [Abstract][Full Text] [Related]
10. Association between
Zerrad C; Lkhider M; Belkouchi A; Tanouti IA; Badre W; Tahiri M; Ayassi S; Marchio A; Pineau P; Benjelloun S; Ezzikouri S
Nucleosides Nucleotides Nucleic Acids; 2023; 42(12):986-1003. PubMed ID: 37330637
[TBL] [Abstract][Full Text] [Related]
11. Gene polymorphisms of TLR2 and TLR3 in HBV clearance and HBV-related hepatocellular carcinoma in a Chinese male population.
Chen D; Xie W; Lu Y; Su S; Nong L; Jia Y; Liu Y; Zhou W; Wang H; Tan A
Int J Biol Markers; 2017 May; 32(2):e195-e201. PubMed ID: 28009434
[TBL] [Abstract][Full Text] [Related]
12. Significance of toll-like receptors 2 and 4 mRNA expression in chronic hepatitis C virus infection.
Shehata MA; Abou El-Enein A; El-Sharnouby GA
Egypt J Immunol; 2006; 13(1):141-52. PubMed ID: 17974158
[TBL] [Abstract][Full Text] [Related]
13. Prognostic impact of toll-like receptors 2 and 4 expression on monocytes in Egyptian patients with hepatocellular carcinoma.
Zahran AM; Zahran ZAM; El-Badawy O; Abdel-Rahim MH; Ali WAM; Rayan A; Abbas El-Masry M; Abozaid MAA; Hetta HF
Immunol Res; 2019 Jun; 67(2-3):157-165. PubMed ID: 31028612
[TBL] [Abstract][Full Text] [Related]
14. Variations in DEPDC5 gene and its association with chronic hepatitis C virus infection in Saudi Arabia.
Al-Anazi MR; Matou-Nasri S; Abdo AA; Sanai FM; Khan MQ; Albenmousa A; Al-Ashgar HI; Khalaf NZ; Al-Ahdal MN; Al-Qahtani AA
BMC Infect Dis; 2014 Dec; 14():632. PubMed ID: 25551790
[TBL] [Abstract][Full Text] [Related]
15. Increased hepatic expression of TLR2 and TLR4 in the hepatic inflammation-fibrosis-carcinoma sequence.
Soares JB; Pimentel-Nunes P; Afonso L; Rolanda C; Lopes P; Roncon-Albuquerque R; Gonçalves N; Boal-Carvalho I; Pardal F; Lopes S; Macedo G; Lara-Santos L; Henrique R; Moreira-Dias L; Gonçalves R; Dinis-Ribeiro M; Leite-Moreira AF
Innate Immun; 2012 Oct; 18(5):700-8. PubMed ID: 22330637
[TBL] [Abstract][Full Text] [Related]
16. Genetic Polymorphism of Epidermal Growth Factor Gene as a Predictor of Hepatocellular Carcinoma in Hepatitis C Cirrhotic Patients.
Baghdadi I; Abu Ella K; El Shaaraway A; Elshayeb E; El-Rebey HS; El Hoseeny M; Naguib M; Nada A
Asian Pac J Cancer Prev; 2020 Jul; 21(7):2047-2053. PubMed ID: 32711431
[TBL] [Abstract][Full Text] [Related]
17. Identification of polymorphisms in the Toll-like receptor gene and the association with allergic rhinitis.
Kang I; Oh YK; Lee SH; Jung HM; Chae SC; Lee JH
Eur Arch Otorhinolaryngol; 2010 Mar; 267(3):385-9. PubMed ID: 19763595
[TBL] [Abstract][Full Text] [Related]
18. Association of TLR2 and TLR4 non-missense single nucleotide polymorphisms with type 2 diabetes risk in a southern Chinese population: a case-control study.
Huang WH; Nie LH; Zhang LJ; Jing LP; Dong F; Wang M; Zhang N; Liu Y; Zhang BH; Chen C; Lin HS; Wei XC; Yang G; Jing CX
Genet Mol Res; 2015 Jul; 14(3):8694-705. PubMed ID: 26345801
[TBL] [Abstract][Full Text] [Related]
19. Genome-Wide Association Study Identifies TLL1 Variant Associated With Development of Hepatocellular Carcinoma After Eradication of Hepatitis C Virus Infection.
Matsuura K; Sawai H; Ikeo K; Ogawa S; Iio E; Isogawa M; Shimada N; Komori A; Toyoda H; Kumada T; Namisaki T; Yoshiji H; Sakamoto N; Nakagawa M; Asahina Y; Kurosaki M; Izumi N; Enomoto N; Kusakabe A; Kajiwara E; Itoh Y; Ide T; Tamori A; Matsubara M; Kawada N; Shirabe K; Tomita E; Honda M; Kaneko S; Nishina S; Suetsugu A; Hiasa Y; Watanabe H; Genda T; Sakaida I; Nishiguchi S; Takaguchi K; Tanaka E; Sugihara J; Shimada M; Kondo Y; Kawai Y; Kojima K; Nagasaki M; Tokunaga K; Tanaka Y;
Gastroenterology; 2017 May; 152(6):1383-1394. PubMed ID: 28163062
[TBL] [Abstract][Full Text] [Related]
20. Clinical Implication of Toll-Like Receptors (TLR2 and TLR4) in Acute Myeloid Leukemia Patients.
Aref S; Abd Elmaksoud ASM; Abd Elaziz S; Mabed M; Ayed M
Asian Pac J Cancer Prev; 2020 Nov; 21(11):3177-3183. PubMed ID: 33247673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
